Peritoneal metastases from colorectal carcinoma: Exploring the potential of immunotherapy as a treatment adjunct

结直肠癌腹膜转移：探索免疫疗法作为辅助治疗的潜力

• 批准号: nhmrc : 1151142
• 金额: $ 5.95万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/peritoneal-metastases-colorectal-treatment-adjunct/1321300
• 关键词: Peritoneal; metastases; colorectal; carcinoma; Exploring

Twenty percent of patients with bowel cancer have disease involving the lining of the abdomen, called the peritoneum. These patients do poorly. The majority are inoperable, and chemotherapy has poor response in these patients. Therefore, there is a dire need to explore new treatments. Newer drugs that stimulate the immune cells to fight cancer have shown promise in other cancers. We aim to assess the potential of this treatment in peritoneal disease, with the aim of improving patient outcomes.

百分之二十的肠癌患者的疾病涉及到腹部的衬里，称为腹膜。这些病人做得很差。大多数是不可手术的，化疗对这些患者的反应很差。因此，迫切需要探索新的治疗方法。刺激免疫细胞对抗癌症的新药物在其他癌症中显示出了希望。我们的目的是评估这种治疗在腹膜疾病中的潜力，目的是改善患者的预后。